Skip to main content

Lantern Pharma Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Lantern Pharma Inc

Did you know?

Capital expenditures decreased by 86% from FY24 to FY25.

Current Price

$2.23

+5.19%
Profile
Valuation (TTM)
Market Cap$24.94M
P/E-1.46
EV
P/B3.82
Shares Out11.18M
P/Sales
Revenue$0.00
EV/EBITDA

Lantern Pharma Inc (LTRN) Insider Trades

LTRN Insider Trading Activity

Track insider trading transactions for Lantern Pharma Inc (LTRN). Monitor recent buys, sells, and option exercises by officers, directors, and 10% beneficial owners. Insider trading activity can signal management confidence or concern about a stock's future prospects.

Current stock price: $2.23. Market cap: $24.94M. This page displays the most recent insider transactions for LTRN, including the insider's name, title, transaction type (purchase, sale, or option exercise), number of shares, and total value. Filter transactions by type to focus on open-market purchases or sales.

Insider buying is often viewed as a bullish signal, as insiders are putting their own capital at risk. Conversely, large insider sales may warrant further investigation. Use GoodMoat's insider trading data alongside financial analysis, quality scores, and valuation tools for a comprehensive view of Lantern Pharma Inc's investment outlook.